Use of Frequency Compression in Severe-profound Hearing Loss Adults
Launched by UNIVERSITY COLLEGE, LONDON · Nov 9, 2020
Trial Information
Current as of June 18, 2025
Completed
Keywords
ClinConnect Summary
Frequency compression is a feature available on some digital hearing aids, which is aimed at increasing the audibility of high frequency sounds. It works by taking sounds above a fixed start frequency and compresses it into lower frequencies where residual hearing is better.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Participants must be over 18 years of age- This study is looking at the use of frequency compression \& its effects of speech perception in adults.
- • 2. No ear surgery that would make it impossible to fit a hearing aid- To ensure limited confounding variables.
- • 3. No history of ear surgery within the last 12 months- To ensure limited confounding variables.
- • 4. No history of ear infection(s) within the last 6 months- To ensure no contraindications and limited confounding variables to testing.
- • 5. No otoscopic abnormality making it impossible to fit a hearing aid- To ensure no contraindications to testing.
- • 6. Bilateral severe-profound hearing impairment with air conduction thresholds \>71dBHL within the frequency range of 250Hz to 4 kHz- To analyse the effects of frequency compression on speech perception within this patient population.
- • 7. Post lingual deafness, with good spoken English- To ensure reliability of speech testing.
- • 8. Previous bilateral digital hearing aid experience (6+ months)- To ensure limited confounding variables.
- • 9. Written consent required.
- Exclusion Criteria:
- • 1. Participants under the age of 18 years.
- • 2. History of ear surgery making it impossible to fit a hearing aid.
- • 3. History of ear surgery within the last 12 months.
About University College, London
University College London (UCL) is a leading global research institution renowned for its commitment to advancing healthcare through innovative clinical trials. As a prominent sponsor of clinical research, UCL leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous investigations aimed at improving patient outcomes and addressing pressing medical challenges. The institution fosters collaboration among researchers, healthcare professionals, and industry partners, ensuring that its trials adhere to the highest ethical standards and regulatory guidelines. UCL's dedication to translating scientific discoveries into practical applications underscores its role as a vital contributor to the advancement of medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Deborah Vickers, Phd
Study Chair
UCL Ear Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials